Can a smartphone app with family support boost opioid treatment success?

NCT ID NCT07451197

Not yet recruiting Disease control Sponsor: University of Wisconsin, Madison Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 08, 2026 · Updated 3 times

Summary

This study tests a text- and web-based tool called FamilyCHESS, designed to help people with moderate to severe opioid use disorder begin and stay on medication. The tool also involves a concerned family member or friend who provides support. Researchers will compare outcomes like medication initiation and continuity between those using FamilyCHESS and those receiving standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: FamilyCHESS (a text- and web-based behavioral intervention)
What this could lead to: If it works, this could provide a practical, family-supported way to help more people begin and continue medication for opioid use disorder, reducing relapse and overdose risk.
What could go wrong: This is an early-stage trial (not yet recruiting) with 338 participants, so results may not apply to everyone. The intervention relies on a willing family member or friend, which may not be available for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

follicular lymphoma opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OPIOID USE DISORDER OPIOID USE DISORDER, MODERATE OPIOID USE DISORDER, SEVERE

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

Northwestern University Feinberg School of Medicine

Chicago, Illinois, 60187, United States
University of Wisonsin-Madison

Madison, Wisconsin, 53706, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.